Jul 11, 2023
CytoSorbents And Humedics Announce Theranostic Collaboration in the Field of Liver Disease
PRINCETON, N.J., July 11, 2023 (GLOBE NEWSWIRE) — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, and Humedics GmbH, a le…
Read more